Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. Cash on Hand 2019–2025
Allogene Therapeutics Inc. annual/quarterly cash on hand history from 2019 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Allogene Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 51.7M, a 31.28% decrease year-over-year.
- Allogene Therapeutics Inc. cash on hand for 2025 were 51.7M, a 31.28% decrease from 2024.
- Allogene Therapeutics Inc. cash on hand for 2024 were 75.2M, a 9.54% decrease from 2023.
- Allogene Therapeutics Inc. cash on hand for 2023 were 83.2M, a 34.33% increase from 2022.
- Allogene Therapeutics Inc. cash on hand for 2022 were 61.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Allogene Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $52 |
| 2024 | $75 |
| 2023 | $83 |
| 2022 | $62 |
| 2021 | $173 |
| 2020 | $183 |
| 2019 | $175 |
| Allogene Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $52 |
| 2024-12-31 | $75 |
| 2023-12-31 | $83 |
| 2022-12-31 | $62 |
| 2021-12-31 | $173 |
| 2020-12-31 | $183 |
| 2019-12-31 | $175 |
Allogene Therapeutics Inc. Cash on Hand — FAQ
Allogene Therapeutics Inc. (ALLO) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALLO's cash on hand history?
The chart and table above show Allogene Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.